Search by Drug Name or NDC
NDC 00536-1311-08 Rugby Chest Congestion Relief 400 mg/1 Details
Rugby Chest Congestion Relief 400 mg/1
Rugby Chest Congestion Relief is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Rugby Laboratories. The primary component is GUAIFENESIN.
MedlinePlus Drug Summary
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 00536-1311-08Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Guaifenesin
Product Information
| NDC | 00536-1311 |
|---|---|
| Product ID | 0536-1311_2122999c-58f1-4620-852b-e0e3acc48620 |
| Associated GPIs | 43200010000340 |
| GCN Sequence Number | 051583 |
| GCN Sequence Number Description | guaifenesin TABLET 400 MG ORAL |
| HIC3 | B3J |
| HIC3 Description | EXPECTORANTS |
| GCN | 18906 |
| HICL Sequence Number | 000271 |
| HICL Sequence Number Description | GUAIFENESIN |
| Brand/Generic | Generic |
| Proprietary Name | Rugby Chest Congestion Relief |
| Proprietary Name Suffix | G450 |
| Non-Proprietary Name | Guaifenesin |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 400 |
| Active Ingredient Units | mg/1 |
| Substance Name | GUAIFENESIN |
| Labeler Name | Rugby Laboratories |
| Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00536-1311-08 (00536131108)
| NDC Package Code | 0536-1311-08 |
|---|---|
| Billing NDC | 00536131108 |
| Package | 60 TABLET in 1 BOTTLE, PLASTIC (0536-1311-08) |
| Marketing Start Date | 2020-09-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.06601 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | CHEST CONGEST RLF 400 MG TAB |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis